Ingenus Pharms Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for INGENUS PHARMS LLC, and what generic alternatives to INGENUS PHARMS LLC drugs are available?
INGENUS PHARMS LLC has eleven approved drugs.
There is one US patent protecting INGENUS PHARMS LLC drugs. There is one tentative approval on INGENUS PHARMS LLC drugs.
There is one patent family member on INGENUS PHARMS LLC drugs in one country and eighteen supplementary protection certificates in eight countries.
Summary for Ingenus Pharms Llc
| International Patents: | 1 |
| US Patents: | 1 |
| Tradenames: | 11 |
| Ingredients: | 11 |
| NDAs: | 11 |
Drugs and US Patents for Ingenus Pharms Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ingenus Pharms Llc | CYCLOPHOSPHAMIDE | cyclophosphamide | SOLUTION;INTRAVENOUS | 212501-003 | Nov 19, 2021 | RX | Yes | Yes | 10,993,952 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Ingenus Pharms Llc | CYCLOPHOSPHAMIDE | cyclophosphamide | SOLUTION;INTRAVENOUS | 212501-001 | Jul 30, 2020 | RX | Yes | Yes | 10,993,952 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Ingenus Pharms Llc | PANTOPRAZOLE SODIUM | pantoprazole sodium | TABLET, DELAYED RELEASE;ORAL | 211368-001 | Mar 1, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ingenus Pharms Llc | TIMOLOL MALEATE | timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 216533-002 | Sep 13, 2022 | AT3 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ingenus Pharms Llc | MELPHALAN HYDROCHLORIDE | melphalan hydrochloride | INJECTABLE;INJECTION | 210947-001 | Feb 18, 2020 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ingenus Pharms Llc | TIMOLOL MALEATE | timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 216533-001 | Sep 13, 2022 | AT3 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ingenus Pharms Llc | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | dorzolamide hydrochloride; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 217260-001 | May 1, 2023 | AT2 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Ingenus Pharms Llc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2016132270 | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Ingenus Pharms Llc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0509752 | SPC/GB99/043 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: DORZOLAMIDE OR AN OPHTHALMOLOGICALLY ACCEPTABLE SALT THEREOF, PREFERABLY DORZOLAMIDE HYDROCHOLORIDE, PLUS TIMOLOL OR AN OPHTHAMOLOGICALLY ACCEPTABLE SALT THEREOF, PREFERABLY TIMOLOL MALEATE; REGISTERED: DK 19045 19980306; UK PL 00025/0373 19980804 |
| 0509752 | 2000C/001 | Belgium | ⤷ Sign Up | PRODUCT NAME: DORZOLAMIDI HYDROCHLORIDUM EQ. DORZOLAMIDUM, TIMOLOLI MALEAS EQ. TIMOLOLUM; NAT. REGISTRATION NO/DATE: 922 IS 180 F 13 19981110; FIRST REGISTRATION: DK 19045 19980306 |
| 2701720 | CR 2022 00054 | Denmark | ⤷ Sign Up | PRODUCT NAME: MELPHALAN FLUFENAMIDE HYDROCHLORIDE; REG. NO/DATE: EU/1/22/1669 20220818 |
| 0509752 | 49/1999 | Austria | ⤷ Sign Up | PRODUCT NAME: DORZOLAMID ODER EIN OPHTHALMOLOGISCH ANNEHMBARES SALZ DAVON, VORZUGSWEISE DORZOLAMIDHYDROCHLORID, UND TIMOLOL ODER EIN OPHTHALMOLOGISCH ANNEHMBARES SALZ DAVON, VORZUGSWEISE TIMOLOLMALEAT; NAT. REGISTRATION NO/DATE: 1-22701, 1-22702 19980828; FIRST REGISTRATION: DK 9794 19980306 |
| 0850926 | C00850926/01 | Switzerland | ⤷ Sign Up | PRODUCT NAME: TAFLUPROST; REGISTRATION NO/DATE: SWISSMEDIC 60548 27.01.2010 |
| 0260415 | C990036 | Netherlands | ⤷ Sign Up | PRODUCT NAME: CARMUSTINE; NAT. REGISTRATION NO/DATE: RVG 24056 19990809; FIRST REGISTRATION: FR 561 907-5 19981210 |
| 0850926 | 11C0020 | France | ⤷ Sign Up | PRODUCT NAME: TAFLUPROST; REGISTRATION NO/DATE IN FRANCE: CIS:6 000 728 O DU 20110328; REGISTRATION NO/DATE AT EEC: 43230 DU 20080430 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
